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RELATIONSHIP BETWEEN HYPERTENSION AND DIABETES 
MELLITUS TYPE 2 WITH BENIGN PROSTATE HYPERPLASIA IN 
MGR. GABRIEL MANEK HOSPITAL ATAMBUA 




Objectives: To evaluate the relationship between hypertension (HT) and diabetes mellitus 
type 2 (DM type 2) with benign prostate hyperplasia (BPH).Material & methods:This is a 
case control study with group A (case) consist of 78 BPH patient and group B (control) 
consist of 78 non BPH patient. DM and HT status from each group was collected. 
Correlation between each variables and odds ratio was analyzed.Results: Mean age was 
66.09 ± 9.05 and 63.40 ± 9.83 years in group A and group B respectively. There is a 
statistical significant correlation between HT (0.001) and DM (0.021) with BPH (p<0.05). 
Patient with hypertension are 7.8 times more likely to suffer from BPH (OR 7.882) and 
patient with DM are 3 times more likely to suffer from BPH.Conclusion: HT and DM type 2 
are significantly related to BPH incidence in Mgr. Gabriel Manek Hospital. Patient with HT 
and DM type 2 are more likely to suffer from BPH. Prevention and management of HT and 
DM type 2 may help to reduce the incidence of BPH. 
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Benign prostate hyperplasia (BPH) is 
a focal enlargement of the peri-urethral 
region of the prostate seen in most aging 
men, which results in symptoms requiring 
clinical intervention in approximately one-
third of men over the age of 60 years.1 
Currently, BPH is the fourth most prevalent 
disease in men aged >50 years.2 In 2013, 
Indonesia has 9.2 million cases of BPH, 
most of them were suffered by men aged 
over 60 years.3 It usually begins as a simple 
micronodular hyperplasia with a 
subsequent macroscopic nodular 
enlargement that may result in bladder 
outlet obstruction and the development of 
lower urinary tract symptoms (LUTS).4 
 
Hypertension is a global problem 
characterized by high morbidity.5 In the 
UK, the National Institute for Health and 
Care Excellence (NICE) defines high blood 
pressure (BP), also known as hypertension, 
as a clinic blood pressure of 140/90 mmHg 
or higher confirmed by a subsequent 
ambulatory blood pressure monitoring 
daytime average of 135/85 mmHg or 
higher.6 The prevalence of hypertension 
based on Riskesdas 2018 in Indonesia is 
34,11% .7 The risk factors of hypertension 
include sedentary lifestyle, stress, visceral 
obesity, potassium deficiency, obesity, salt 
sensitivity, alcohol intake, and vitamin D 
deficiency.8 
 
And diabetes mellitus (DM) affects 
7,8% of US population. In 1996, Bourke 
and Griffin first reported the higher 
prevalence of DM among men subjected to 
prostatectomy than in general male 
population. Insulin is involved in the 
pathogenesis of BPH through its action on 
sympathetic nerve activity and by insulin 
itself as a mitogen and a growth factor for 
prostate epithelial cells.9 
 
Although the etiology of BPH is still 
largely unresolved and poorly understood, 
DM is known to be associated with and 
increased of hypertension and greater 
severity of BPH.10 Single components of 
metabolic syndrome (obesity, dyslipidemia, 
hypertension, and insulin resistance) as 
well as the syndrome itself may predispose 
patients to a higher risk of BPH and lower 
urinary tract symptoms.2 
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OBJECTIVE 
The aim of this study is to evaluate 
the relationship between hypertension and 
DM type 2 with BPH patients in Mgr. 
Gabriel Manek Hospital Atambua. 
MATERIAL & METHOD 
This is a case control study with 
group A (case) consist of 78 BPH patient 
and group B (control) consist of 78 non 
BPH patient. DM and HT status from each 
group was collected. Correlation between 
each variables and odds ratio was analyzed. 
 
The diagnosis of DM in this study 
was defined as blood glucose level > 
200mg/dl; hypertension was definedby SBP 
≥140 mmHg or DBP of ≥90 mmHg 
according to JNC VII. 
 
Two type of statistics were 
performed, univariate analytic to show 
distribution of each risk factors and 
bivariate analytic statistics using chi square 
and odd ratio (OR) to evaluate the 
relationship between BPH and risk factors. 
 
RESULTS 
Mean age was 66.09 ± 9.05 and 63.40 
± 9.83 years in group A and group B 
respectively. Based on Table 1, it can be 
seen that the patient group is divided into 
groups of BPH and non-BPH patients, then 
differentiated into patients who have a 
history of hypertension – DM type 2 and do 
not have a history of hypertension – DM 
type 2. BPH patients are divided into 
several age ranges, 40-49 years (2.56%), 
50-59 years (23.08%), 60-69 years 
(32.05%), 70-79 years (35.90 %), and 80-
89 years (0.64%). 
 
 
Table 1. Sample Characteristic 
Risk Factor   Case Group Control Group 
    N= 78 N= 78 
Age (Mean ± SD) (years)  66.09 ± 9.05 63.40 ± 9.83 
Age Group (years) (N (%))     
  40-49 2 (2,56%) 5 (6,41%) 
  50-59 18 (23,08%) 20 (25,64%) 
  60-69 25 (32,05%) 28 (35,90%) 
  70-79 28 (35,90%) 22 (28,20 %) 
  80-89 5 (0,64%) 3 (3,85%) 
Hypertension (N(%))       
  No Hypertension 34 (43,59%) 67 (85,89%) 
  Hypertension 44 (56,41%) 11 (14,10%) 
Hypertension Categories 
(N(%))       
  Normal 34 (43.59%) 67(85,89%) 
  
Hypertension 
Grade 1 30 (38,46%) 6 (7,69%) 
  
Hypertension 
Grade 2 10 (12,82%) 3 (3,85%) 
  
Hypertension 
Grade 3 4 (5,13%) 2 (2,56%) 
Diabetes Mellitus Type 2 
(N(%))      
  No Diabetes 62 (79,49%) 72 (92,31%) 
  
Diabetes Mellitus 
Type 2 16 (20,51%) 6 (7,69%) 
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There was an increase in the number 
of BPH incidences in line with the 
increasing range of age groups, except in 
the 80-89-year age group. The total number 
of hypertensive patients in the case group 
was 56.41% and 14.10% in the control 
group. The distribution of the degree of 
hypertension in the case group was grade 1 
(38.46%), grade 2 (12.82%), and grade 3 
(5.13%). And for the prevalence of type 2 
diabetes mellitus patients, there were 16 
patients (20.51%) in BPH patients and 6 
patients (7.69%) in non BPH patients. 
 
Analysis of the relationship between 
the independent variable (history of 
hypertension and DM type 2) and the 
dependent variable (BPH) in this study 
used the chi square test. 
 
 






(2-sided) Exact Sig. (1-sided) 
 
HT DM  HT DM HT DM HT DM 
Pearson Chi-Square 30.582a 5.292a 1 .000 .021   
Continuity Correctionb 28.757  1 .000 .038   
Likelihood Ratio 32.185 4.286 1 .000 .019   
Fisher's Exact Test    .000 .037 .000 .018 
Linear-by-Linear 
Association 
30.386 5.258 1 .000 .022 
  
McNemarTestb    .001c .000c  
N of Valid Cases 156     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 27.50. 
b. Computed only for a 2x2 table     
c. Binomial distribution used.     
 
In table 2, the chi square value in 
the statistical table with a significance of 
0.05 and df = 1 is 3,841. The Chi square 
count for HT and DM are more than the 
Chi square table, namely 30.582 (> 3,841) 
and 5.292 (> 3.841). The significance is 
0.000 (<0.05) for HT and 0.021 (<0.05) for 
DM. 
 






 Lower Upper 






For cohort BPH = 
Patient Non BPH 
3.317 1.920 5.729 
For cohort BPH = 
Patient BPH 
.421 .310 .570 
N of Valid Cases 156   
 
In table 3, it can be seen that the 
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Table 4. Risk Estimation for DM Type 2 
 
 Value 95% Confidence 
Interval 
Lower Upper 
Odds Ratio for 



























































In table 4, we can see that the Odds 
Ratio (OR) value of 3.097 means that 
people who have diabetes are more likely 
to experience BPH incidence 3.097 times 
than people who do not have diabetes. 
 
DISCUSSION 
BPH is a progressive condition 
characterized by prostate enlargement 
leading to lower urinary tract symptoms 
(LUTS).1 BPH is seen frequently in males 
older than 50 yr. and in 50% males aged 
60-70 yr. with LUTS; 25% of the latter 
need surgical treatment.12 Our results 
demonstrated that BPH is more frequent in 
older aged group.We have 35,90% patients 
with BPH in group age 70-79 years old. 
 
Several risk factors are involved 
the occurrence of BPH disease such as age, 
historyfamily, obesity, sexual activity, lack 
exercise, smoking habits, drinking habits 
alcoholic beverages.13 
 
In this study, there is a statistical 
significant correlation between 
hypertension (0.00) and DM type 2 (0.021) 
with BPH (p<0.05).  
 
 The prevalence of BPH and arterial 
hypertension increase with age, and hence 
both are frequent disease states in the 
elderly male.12 Hypertension was also 
associated with BPH/LUTS in several 
animal models and epidemiologic. Golomb 
et al reported that spontaneously 
hypertensive rats develop BPH-like 
features with aging in the absence of any 
inductive exogenous agents. Conversely, 
their normotensive counterparts did not 
develop such features.2 The diagnosis of 
hypertension is made on the basis of blood 
pressure measurements, but a reliable 
diagnosis requires multiple readings at 
different times under well-defined 
condition.12 Since our data in this study had 
not been primarily generated with purpose 
of studying hypertension, we have used 
only data by the diagnosis of hypertension 
from patient’s medical records. 
 
A previous study has detected a 
higher prevalence of hypertension in men 
undergoing BPH related surgery than in a 
series of control patients.An increased 
sympathetic tone and/or increased α1-
adrenoceptor function have long implicated 
in the pathophysiology of essential 
hypertension. While BPH was originally 
thought to result primarily from obstruction 
of bladder outflow due to increased organ 
size, later concepts have emphasized that 
increased prostatic smooth muscle tone 
may also contribute to obstruction as 
dynamic component since the latter is 
primarily controlled by neuronally released 
noradrenaline acting on smooth muscle α1-
adrenoceptors.12 
 
Recent studies suggest that 
hyperinsulinemia secondary insulin 
resistance and the components of metabolic 
syndrome are risk factors for BPH.In the 
study conducted by Dahle et al, increased 
serum insulin level was related to increased 
BPH risk.11 The major endocrine aberration 
in connection with metabolic syndrome is 
hyperinsulinemia. Insulin is an independent 
risk factor and a promoter of BPH. Insulin 
resistance may change the risk of BPH 
through several biological pathways. 
Hyperinsulinemia stimulates the liver to 
produce more insulin-like growth factor 
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(IGF), another mitogen and an anti-
apoptotic agent which binds insulin 
receptor/IGF receptor and stimulates 
prostate growth.9Similar to other study, our 
results demonstrated the patients with 
diabetes had a significantly higher risk to 
have BPH.  
 
The odds ratio for HT and DM type 2 
are 7.882 and 3.097 respectively. This 
indicates that patient with HT are 7.8 times 
more likely to suffer from BPH compare to 
normotension patient whereas patient with 
DM type 2 are 3.097 times more likely to 
suffer from BPH compare to patient 
without DM type 2. 
 
CONCLUSION 
BPH is common and a major health 
problem especially in elderly male groups. 
The correlations between hypertension and 
DM type 2 with BPH have been observed 
in many studies. We established in our 
study that hypertension and DM type-2 
were significantly related to BPH incidence 
in Mgr. Gabriel Manek Hospital. Patient 
who have diabetes and hypertension are 
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